This research investigates CRISPR acceptance in diverse populations, highlighting ethical and cultural factors influencing attitudes.
This research investigates the intersection of biotechnology, ethics, and theology, specifically focusing on how age, religion, and geographic background shape public acceptance of CRISPR-based gene editing for Congenital Heart Diseases (CHD).Drawing on a global dataset of 500 survey responses across 70 countries, the study analyzes patterns in technological trust, moral reasoning, and reproductive decision-making. Key findings include:• Generational Divides: Younger respondents (Gen Z and Millennials) express significantly higher support for therapeutic gene editing and greater ethical flexibility than older demographics.• Religious Influence: Religious affiliation remains a strong predictor of attitudes, with Muslim and Christian participants exhibiting higher caution regarding "divine will" compared to atheist or agnostic respondents.• Geographic Trends: Results indicate higher acceptance in Western regions linked to scientific literacy, while South Asian and Middle Eastern regions reflect more conservative, faith-aligned positions.By integrating biomedical literature on CHD-related mutations (such as TBX5 and GATA4) with socio-cultural data, this paper highlights the necessity of a "localized" approach to bioethics. It argues that for CRISPR to be globally viable, scientific advancement must be reconciled with diverse cultural and religious frameworks.
No takes yet. Share an insight, caveat, or question.
Laibaa Zahid (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: